Delivery Order SPE2DB20D3103-SPE2DB26FL4H4
Award Date 10/29/25
Potential Completion Date 10/30/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,240.57 to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg, a Schedule II controlled substance commonly prescribed for attention-deficit/hyperactivity disorder. The contract was competitively awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and is classified as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 20 mg, a controlled substance commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $1,072.01, was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 20 mg, a Schedule II controlled substance commonly prescribed for attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $4,136.15, was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. The award leverages AmerisourceBergen's established position as a critical...
- The Defense Logistics Agency awarded a $2,051.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 30 mg, a Schedule II controlled substance commonly used to treat attention deficit hyperactivity disorder. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $2,949.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg, a controlled substance commonly prescribed for attention deficit hyperactivity disorder. This delivery order, issued on September 8, 2025, with completion targeted for September 9, 2025, represents a routine pharmaceutical procurement to support federal medical supply needs. The contract was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a $2,010.28 delivery order to AmerisourceBergen Drug Corp for 90 capsules of Lisdexamfetamine 60 mg, a controlled pharmaceutical product used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for 100 capsules of Lisdexamfetamine 40 mg, a controlled stimulant medication commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at approximately $2.98K, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99B prime vendor agreement running...
- The Defense Logistics Agency awarded a $2,181.08 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 30 mg, a controlled pharmaceutical used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, which became effective on August 5, 2025 with an ultimate completion date of August 6, 2025, was awarded without a set-aside designation through open competition. The order will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,768.95 for 90 capsules of Lisdexamfetamine 60 mg on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency has awarded a $3,574.42 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 10 mg, a controlled substance commonly prescribed for attention-deficit/hyperactivity disorder treatment. The contract is firm fixed price with no set-aside designation and is scheduled for completion by October 24, 2025. This delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...